International Research Network on Dravet Syndrome and Refractory Epilepsy

About us

An initiative of ApoyoDravet for the development of a collaborative network between research groups with an interest on Dravet Syndrome and Refractory Epilepsy.

RESEARCH GROUPS
PROJECTS

Onintza Sagredo	Cannabinoids and Dravet syndrome	Universidad Complutense (Madrid)
Manuel Álvarez Dolado	Cell-based Therapy for Neuropathologies Lab	Andalusian Center for Molecular Biology and Regenerative Medicine, CABIMER
Jon Andoni Duñabeitia	Centro de Ciencia Cognitiva (C3)	Nebrija University
Ibo Galindo	Developmental Biology and Disease Models	Centro de Investigación Príncipe Felipe (CIPF) Valencia
Ainhoa Alzualde	Dravet unit in Biobide	Biobide (Donostia)
Dr. Antonio Gil-Nagel Rein	Epilepsy Unit Ruber International Hospital	Ruber International Hospital Madrid
Sandra Acosta Verdugo	Functional neurogenetics	Centro Universitat Pompeu Fabra (Barcelona)
Víctor Puntes	Inorganic Nanoparticles Group	Vall d´ Hebrón Hospital (Barcelona)
Alan Talevi	Laboratory of Bioactive Research and Development (LIDeB)	Universidad La Plata Buenos Aires Argentina
Jan Tonnesen	Laboratory of Neuronal Excitability	Basque Center for Neuroscience Achucarro
Isabel Del Pino	Neural Plasticity Group	Centro de Investigación Príncipe Felipe (CIPF) Valencia
Juan Casto Rivadulla	Neurocom-Neurofisiología experimental	Universidad de A Coruña
Juan Manuel Encinas	The Neural Stem Cell and Neurogenesis Lab	Basque Center for Neuroscience Achucarro

INVESTIGADOR PRINCIPAL	GRUPO	CENTRO
Dra. Sandra Acosta Verdugo	Neurogenética funcional	Centro Universitat Pompeu Fabra (Barcelona)
Dr. Juan Manuel Encinas	Laboratory of Neural Stem Cells and Neurogenesis	Basque Center for Neuroscience Achucarro
Dr. Paolo Bonifazi	Computational Neuroimaging Lab	Biocruces Health Research Institute (Barakaldo - Bizkaia)
Dr. Víctor Puntes	Nanopartículas Inorgánicas	Vall d´ Hebrón Hospital (Barcelona)
Dra. Ainhoa Alzualde	Unidad Dravet en Biobide	Biobide (Donostia)
Dr. Ibo Galindo	Unidad Mixta Centro de Investigación Príncipe Felipe (CIPF Valencia), Universidad Politécnica Valencia	Laboratorio de Biología Del Desarrollo y Modelos de Enfermedad (Valencia)
Dr. Manuel Álvarez Dolado	Terapia celular en neuropatologías	Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER-Sevilla)
Dra. Onintza Sagredo	Cannabinoides	Universidad Complutense (Madrid)
Dr. Jan Tonnensen	Laboratory of neuronal excitability	Basque Center for Neuroscience (Leioa)
Dr. Alan Talevi	Universidad La Plata Buenos Aires Argentina	Laboratorio de investigación y desarrollo de bioactivos (LIDeB) Universidad nacional de la Plata (Buenos Aires)
Dr. Juan Casto Rivadulla	Grupo de Investigación Neurociencia y Control Motor	Universidad de A Coruña

Anti-oxidant/anti-inflamatory nanoparticles to protect the brain from excess electrophysiology and to mitigate damage post-crisis	(Inorganic Nanoparticles)
Cell Therapy with GABAergic interneuron precursors for Early Infantil Epileptic Encephalopathies (S. Dravet, S. West y S. Stxbp1)	(Cell-based Therapy for Neuropathologies Lab)
Characterization of the didys552 zebrafish mutant line (mutation in snc1lab gene) and set up of an efficacy drug screening assay using reference compounds	(Dravet unit in Biobide)
Creation of a therapeutic drug monitoring (TDM) unit for the optimization of the Dravet syndrome pharmacological therapy	(Laboratory of Bioactive Research and Development (LIDeB))
Design, synthesis and pharmacological evaluation of new neuroprotective agents oriented to the tratment of Dravet syndrome	(Laboratory of Bioactive Research and Development (LIDeB))
Efecto de campos magnéticos estáticos de intensidad moderada en modelos de epilepsia y síndrome de Dravet	(Neurocom-Neurofisología experimental)
Intrinsic neuronal excitability and spontaneous 1 activity underlie cortical abnormalities upon Nr2f1/COUP-TFI deficiency	(Neural Plasticity Group)
Investigating Epilepsy by Super-resolution Imaging of Synapses and the Extracellular Space in Live Brain Tissue	(Laboratory of Neuronal Excitability)
Precision Medicine in Dravet Syndrome	(Developmental Biology and Disease Models)
Reactive Neurogenesis and Gliogenesis in a Dravet Syndrome Mouse Model	(The Neural Stem Cell and Neurogenesis Lab)
The effect of beta-caryophyllene treatment in a murine model of Dravet syndrome	(Cannabinoides y síndrome de Dravet)
The endocannabinoid system study in Dravet syndrome	(Cannabinoids and Dravet syndrome)

NEWS

2019-03-21

Biobide, Fundación Dravet Argentina and Asociación ApoyoDravet, promote the search for drugs for Dravet Syndrome

DONATE

The Apoyodravet Association (AD) central pillars are social innovation, patient-oriented technology and the promotion of research in the service of disease modification.

If you want to stay updated on the INDRE international research network please...

SIGN UP

International Research Network on Dravet Syndrome and Refractory Epilepsy

An initiative of ApoyoDravet for the development of a collaborative network between research groups with an interest on Dravet Syndrome and Refractory Epilepsy.

NEWS

Sponsors